A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).

Davies, G A

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2). [electronic resource] - Thrombosis research 02 2018 - 88-92 p. digital

Publication Type: Journal Article

1879-2472

10.1016/j.thromres.2017.04.003 doi


Central Venous Catheters--adverse effects
Factor Xa Inhibitors--pharmacology
Female
Humans
Male
Middle Aged
Neoplasms--complications
Prospective Studies
Rivaroxaban--pharmacology
Upper Extremity Deep Vein Thrombosis--drug therapy